EUVIMEDEUVIMED entdecken
Crossref

Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways

Vishal Kumar Vishwakarma iD, Sadia Shah, Tajpreet Kaur, Amrit Pal Singh, Sudheer Kumar Arava, Niraj Kumar, Raj Kanwar Yadav, Sushma Yadav, Taruna Arora, Harlokesh Narayan Yadav iD

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Vishal Kumar Vishwakarma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Cardiomyopathies, Enalapril. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Diabetic cardiomyopathy (DC) is one of the severe secondary complications of diabetes mellitus in humans. Vinpocetine is an alkaloid having pleiotropic pharmacological effects. The present study is designed to investigate the effect of vinpocetine in DC in rats.

Methods

Rats were fed a high-fat diet for nine weeks along with single dose of streptozotocin after the second week to induce DC. The haemodynamic evaluation was performed to assess the functional status of rats using the Biopac system. Cardiac echocardiography, biochemical, oxidative stress parameters and inflammatory cytokine level were analysed in addition to haematoxylin–eosin and Masson’s trichome staining to study histological changes, cardiomyocyte diameter and fibrosis, respectively. Phosphodiesterase-1 (PDE-1), transforming growth factor-β (TGF-β) and p-Smad 2/3 expression in cardiac tissues were quantified using western blot/RT-PCR. Key finding Vinpocetine treatment and its combination with enalapril decreased the glucose levels compared to diabetic rats. Vinpocetine improved the echocardiographic parameters and cardiac functional status of rats. Vinpocetine decreased the cardiac biochemical parameters, oxidative stress, inflammatory cytokine levels, cardiomyocyte diameter and fibrosis in rats. Interestingly, expressions of PDE-1, TGF-β and p-Smad 2/3 were ameliorated by vinpocetine alone and in combination with enalapril.

Conclusions

Vinpocetine is a well-known inhibitor of PDE-1 and the protective effect of vinpocetine in DC is exerted by inhibition of PDE-1 and subsequent inhibition of the expression of TGF-β/Smad 2/3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic CardiomyopathiesEnalaprilAnimalsHumansRatsFibrosisPhosphoric Diester HydrolasesSignal TransductionTransforming Growth Factor betaVinca Alkaloids

Stichwörter der Autor:innen

TGF-βdiabetic cardiomyopathyoxidative stressphosphodiesterase-1vinpocetine

Substanzen

EnalaprilPhosphoric Diester HydrolasesTransforming Growth Factor betavinpocetineVinca Alkaloids

Autor:innen und Institutionen

  • Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pharmacology, Khalsa College of Pharmacy, Amritsar, India.
  • Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Neuroanesthesiogy and Critical Care, All India Institute of Medical Sciences, New Delhi, India.
  • Department Nephrology, All India Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Vishal Kumar Vishwakarma, Harlokesh Narayan Yadav

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Vishwakarma, V. K., Shah, S., Kaur, T., Singh, A. P., Arava, S. K., Kumar, N., Yadav, R. K., Yadav, S., Arora, T., & Yadav, H. N. (2023). Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad043

Vancouver

Vishwakarma VK, Shah S, Kaur T, Singh AP, Arava SK, Kumar N, et al. Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad043

BibTeX
@article{Vishwakarma2023,
  author = {Vishwakarma, Vishal Kumar and Shah, Sadia and Kaur, Tajpreet and Singh, Amrit Pal and Arava, Sudheer Kumar and Kumar, Niraj and Yadav, Raj Kanwar and Yadav, Sushma and Arora, Taruna and Yadav, Harlokesh Narayan},
  title = {Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad043}
}
Kostenlos starten →